Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine

Details for Australian Patent Application No. 2009306733 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Jautelat, Rolf; Lucking, Ulrich; Siemeister, Gerhard; Schulze, Julia; Lienau, Philip

Agent Davies Collison Cave

Pub. Number AU-A-2009306733

PCT Pub. Number WO2010/046035

Priority 08167113.3 21.10.08 EP

Filing date 9 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/046035 Priority application(s): WO2010/046035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009306754-Dishwasher

2009306723-Pyrimidine and triazine sulfonamide derivates as B1 bradykinin receptor (B1R) inhibitors for treating pain